Ganymed Pharmaceuticals Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 85

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.41B

  • Investors
  • 2

Ganymed Pharmaceuticals General Information

Description

Developer of antibody therapeutics for the treatment of solid cancers. The company focuses on building a pipeline of antibody therapeutics targeting solid cancers with medical needs and large-market potential and on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency as well as mitigates the threat of toxicity.

Contact Information

Website
www.ganymed-pharmaceuticals.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • An der Goldgrube 12
  • 55131 Mainz
  • Germany
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Astellas Pharma
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • An der Goldgrube 12
  • 55131 Mainz
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ganymed Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 11-Nov-2016 $1.41B Completed Generating Revenue
7. Later Stage VC (Series E) 18-Nov-2013 Completed Generating Revenue
6. Later Stage VC (Series D) 18-Nov-2008 Completed Generating Revenue
5. Merger/Acquisition 21-Aug-2008 Completed Generating Revenue
4. Later Stage VC (Series C) 18-Apr-2007 Completed Generating Revenue
3. Early Stage VC (Series B) 06-Jul-2005 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Jun-2002 $8.14M $8.14M Completed Startup
1. University Spin-Out 01-Jan-2001 Completed Startup
To view Ganymed Pharmaceuticals’s complete valuation and funding history, request access »

Ganymed Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody therapeutics for the treatment of solid cancers. The company focuses on building a pipeline of ant
Drug Discovery
Mainz, Germany
85 As of 2016

Cleveland, OH
 

Needham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ganymed Pharmaceuticals Competitors (45)

One of Ganymed Pharmaceuticals’s 45 competitors is Abeona Therapeutics, a Corporation company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abeona Therapeutics Corporation Cleveland, OH
Verastem Formerly VC-backed Needham, MA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
BSP Pharmaceuticals Corporation Latina Scalo, Italy
You’re viewing 5 of 45 competitors. Get the full list »

Ganymed Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ganymed Pharmaceuticals Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATS Beteiligungsverwaltung Family Office Majority
Angel (individual) Minority
First Capital Partners (Germany) PE/Buyout Minority
Future Capital Investor Venture Capital Minority
Ingro Finanz Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Ganymed Pharmaceuticals FAQs

  • When was Ganymed Pharmaceuticals founded?

    Ganymed Pharmaceuticals was founded in 2001.

  • Where is Ganymed Pharmaceuticals headquartered?

    Ganymed Pharmaceuticals is headquartered in Mainz, Germany.

  • What is the size of Ganymed Pharmaceuticals?

    Ganymed Pharmaceuticals has 85 total employees.

  • What industry is Ganymed Pharmaceuticals in?

    Ganymed Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Ganymed Pharmaceuticals a private or public company?

    Ganymed Pharmaceuticals is a Private company.

  • What is the current valuation of Ganymed Pharmaceuticals?

    The current valuation of Ganymed Pharmaceuticals is .

  • What is Ganymed Pharmaceuticals’s current revenue?

    The current revenue for Ganymed Pharmaceuticals is .

  • How much funding has Ganymed Pharmaceuticals raised over time?

    Ganymed Pharmaceuticals has raised $144M.

  • Who are Ganymed Pharmaceuticals’s investors?

    ATS Beteiligungsverwaltung, , First Capital Partners (Germany), Future Capital Investor, and Ingro Finanz are 5 of 14 investors who have invested in Ganymed Pharmaceuticals.

  • Who are Ganymed Pharmaceuticals’s competitors?

    Abeona Therapeutics, Verastem, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, and BSP Pharmaceuticals are some of the 45 competitors of Ganymed Pharmaceuticals.

  • When was Ganymed Pharmaceuticals acquired?

    Ganymed Pharmaceuticals was acquired on 11-Nov-2016.

  • Who acquired Ganymed Pharmaceuticals?

    Ganymed Pharmaceuticals was acquired by Astellas Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »